1022P A phase II trial of the IO102-IO103 vaccine plus pembrolizumab: Completed cohort for first-line (1L) treatment of advanced squamous cell carcinoma of the head and neck (SCCHN).
Saved in:
| Title: | 1022P A phase II trial of the IO102-IO103 vaccine plus pembrolizumab: Completed cohort for first-line (1L) treatment of advanced squamous cell carcinoma of the head and neck (SCCHN). |
|---|---|
| Authors: | Riess, J.W.1 (AUTHOR), Spicer, J.2 (AUTHOR), Seiwert, T.3 (AUTHOR), Villaflor, V.4 (AUTHOR), Rubio Perez, J.5 (AUTHOR), Shaw, P.H.6 (AUTHOR), Soria Rivas, A.7 (AUTHOR), Chaney, M.8 (AUTHOR), Abildgaard, C.9 (AUTHOR), Patel, P.10 (AUTHOR), Iglesias, M.10 (AUTHOR), Ahmad, Q.11 (AUTHOR), McDowell, D.11 (AUTHOR), Garrido Lopez, P.7 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS691-S691. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1081 |
